TrialBlood2012

A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515.

Alison T Stopeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.